Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 566 of 1,261
  1. US 9974781

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted May 22, 2018 · Expires May 17, 2038

    granted
  2. US 9974785

    Aromatic heterocyclic derivatives and pharmaceutical applications thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  3. US 9974744

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  4. US 9974793

    Emulsion formulations of aprepitant

    Heron Therapeutics, Inc. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  5. US 9974789

    Substituted pyrazolopyrimidines as glucocerebrosidase activators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 22, 2018 · Expires May 17, 2038

    granted
  6. US 9975862

    Arylpiperazine derivatives and methods of utilizing same

    REVIVA PHARMACEUTICALS, INC. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  7. US 9975867

    Synthetic process for preparing 2-furoic acid derivatives

    Dermira, Inc. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  8. CA 3043000

    DERIVES DE PROSTAGLANDINE LIBERANT DE L'OXYDE NITRIQUE POUR LE TRAITEMENT DU GLAUCOME A TENSION NORMALE

    BAUSCH & LOMB [US] · Granted May 17, 2018 · Expires May 12, 2038

    granted
  9. EP 3320902

    VERFAHREN ZUR BEHANDLUNG VON ERKRANKUNGEN MIT ISOINDOLINVERBINDUNGEN

    CELGENE CORP [US] · Granted May 16, 2018 · Expires May 11, 2038

    granted
  10. US 9968631

    Method for treatment of pulmonary fibrosis

    GALECTIN THERAPEUTICS, INC. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  11. US 9969705

    Fused heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 15, 2018 · Expires May 10, 2038

    granted
  12. US 9968653

    Angiopoietin-based interventions for treating cerebral malaria

    REGENERON PHARMACEUTICALS, INC. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  13. US 9969709

    Guanidinobenzoic acid ester compound

    Takeda Pharmaceutical Company Limited · Granted May 15, 2018 · Expires May 10, 2038

    granted
  14. US 9969803

    Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted May 15, 2018 · Expires May 10, 2038

    granted
  15. US 9969695

    N-substituted imidazole carboxylic ester chiral compound containing an ether side chain, its preparation and application

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted May 15, 2018 · Expires May 10, 2038

    granted
  16. US 9968638

    Compositions and methods for transplantation of colon microbiota

    Regents of the University of Minnesota · Granted May 15, 2018 · Expires May 10, 2038

    granted
  17. US 9969970

    DNA-cell conjugates

    The Regents of the University of California · Granted May 15, 2018 · Expires May 10, 2038

    granted
  18. US 9969804

    Methods and compositions for treating and preventing disease associated with alpha-V beta-8 integrin

    The Regents of the University of California · Granted May 15, 2018 · Expires May 10, 2038

    granted
  19. US 9969790

    Compositions and methods for immunomodulation in an organism

    UNIVERSITY OF CONNECTICUT · Granted May 15, 2018 · Expires May 10, 2038

    granted
  20. US 9969754

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  21. US 9969777

    Mutant spike protein extending the tissue tropism of infectious bronchitis virus (IBV)

    The Pirbright Institute · Granted May 15, 2018 · Expires May 10, 2038

    granted
  22. US 9969719

    Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug

    Medshine Discovery Inc. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  23. US 9969742

    Imidazotriazinone compounds

    IRONWOOD PHARMACEUTICALS, INC. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  24. US 9968674

    Methods and compositions comprising a combination of a VEGF Trap and an anti-CTLA-4 antibody

    REGENERON PHARMACEUTICALS, INC. · Granted May 15, 2018 · Expires May 10, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.